Deciphering the Active Compounds and Mechanisms of HSBDF for Treating ALI via Integrating Chemical Bioinformatics Analysis

• Váldodahkkit: Yanru Wang (Dahkki), Xiaojie Jin (Dahkki), Qin Fan (Dahkki), Chenghao Li (Dahkki), Min Zhang (Dahkki), Yongfeng Wang (Dahkki), Qingfeng Wu (Dahkki), Jiawei Li (Dahkki), Xiuzhu Liu (Dahkki), Siyu Wang (Dahkki), Yu Wang (Dahkki), Ling Li (Dahkki), Jia Ling (Dahkki), Chaoxin Li (Dahkki), Qianqian Wang (Dahkki), Yongqi Liu (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2022-06-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

The Huashi Baidu Formula (HSBDF), a key Chinese medical drug, has a remarkable clinical efficacy in treating acute lung injury (ALI), and it has been officially approved by the National Medical Products Administration of China for drug clinical trials. Nevertheless, the regulated mechanisms of HSBDF...